ClinicalTrials.gg

Arthritis, Gouty clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 47 studies for Arthritis, Gouty across more than 10 countries. 16 are recruiting or about to start. 34 of them are mainly about Arthritis, Gouty (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-12.

Status

Completed
21
Recruiting
10
Not yet recruiting
5
Status unknown
5
Terminated
2
Active, not recruiting
2

Phase

Phase 2
16
Phase 3
10
Phase 1
3
Phase 4
2

Where

United States
15
China
11
Taiwan
9
Russian Federation
5
Germany
4
Spain
4

Who develops what

Add Arthritis, Gouty to watchlistPro · free during the betaEvery Monday by email · turn it off any time

Every program with a company-led study here in the last two years, whatever its size: 7 programs from 6 companies, 7 with this as their studies’ main aim; 1 with a live phase 3 study; 4 primary completions in the next 12 months. Compare Swedish Orphan Biovitrum, 3SBio and Innovent Biologics here →

Comparator & background therapies

What other companies’ phase 2+ studies give as the comparator or the background here (its leading trial sponsor and partners left out): a sign of what new drugs are measured against, not by itself the standard of care, its prescriptions or its market.

DrugLeading trial sponsor · rightsCompanies, last 5 years
betamethasone sodium phosphateRecent, limited
Evidence
  • NCT07453004 · TJ Biopharma Co., Ltd. · Phase 2 · live · comparator · “Compound betamethasone” · registered Feb 2026
Surface Ophthalmics, Inc.100% of its industry studies11 study
betamethasone dipropionateRecent, limited
Evidence
  • NCT07453004 · TJ Biopharma Co., Ltd. · Phase 2 · live · comparator · “Compound betamethasone” · registered Feb 2026
LEO Pharma67% of its industry studiesUS: off-patent, 29 generics marketed11 study
ColchicineRecent, limited
Evidence
  • NCT07708181 · 3SBio Inc. · Phase 2 · live · comparator · “Colchicine 0.5 mg” · registered Jul 2026
  • NCT06270225 · 3SBio Inc. · Phase 2 · live · comparator · “Colchicine 0.5 mg” · registered Feb 2024
Mutual Pharmaceutical Company, Inc.70% of its industry studiesUS: off-patent, 18 generics marketedEU: Agepha Pharma s.r.o. (EMA 2026)12 studies

Programs

“Meets, by arms” reads each study’s arms: vs its arm against the therapy’s; + X vs a combination against it; added to it plus the therapy against the therapy; studied with given together only. The next primary completion is the next phase-3 study’s when there is one.

In phase 3Company
EtoricoxibPhase 4 trial recorded☆ Track1 live phase-3 study: NCT06863701Laboratorios Silanes S.A. de C.V.

The 1 in phase 3 with the nearest primary completion, of 7 programs — sign in to see the whole list, free: filter by phase and aim, sort by late development, direct comparisons or the next primary completion.

Primary completion in the next 12 months (4)

Live phase 2 and 3 studies of these programs. Primary completion is when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced.

  • Nov 2026 est.AR882, XOI Low Dose · Swedish Orphan Biovitrum · Phase 2 main aimNCT07116746 Evaluation of Efficacy and Safety of AR882 and XOI Co-administration in Uricase Treatment Failed Patients — primary endpoint: Serum urate (uric acid) (sUA) level < 6 mg/dL at month 6 · 15 enrolled
  • 31 Dec 2026 est.Etoricoxib · Laboratorios Silanes S.A. de C.V. · Phase 3 main aimNCT06863701 Efficacy Anda Safety of Etoricoxib With Betamethasone for the Treatment of Acute Gout Arthritis — primary endpoint: Compare the degree of pain in the affected joint (using the Likert pain scale) on days 2, 5, and 8, according to their baseline measurement in each treatment group. · 72 enrolled
  • 11 May 2027 est.IBI3011 · Innovent Biologics, Inc. · Phase 2 main aimNCT07842497 A Study of Efficacy and Safety of IBI3011 in Subjects With Acute Gouty Arthritis — primary endpoint: The change in the gout pain intensity in the target joint measured by VAS · 132 enrolled

1 more — sign in to see them all, free.

Read from ClinicalTrials.gov, industry-led studies. Main aim: this is the study’s judged main condition; named, not the main aim: the sponsor names it, the study is about something else; registry mapping only: only the registry’s mapping put it here. Leading trial sponsor is the company leading the most industry studies of a drug, a measure of trial activity, not of rights. US and EU rights, and Approved: from the regulators’ records (FDA’s Drugs@FDA via openFDA; EMA’s medicines data) — the holder of a marketed or authorized original, generics and other companies’ versions; not rights elsewhere, nor approval for this condition. Phase 4 trial recorded, where neither lists it: a phase 4 study exists somewhere. Not read yet: labels by indication, exclusivity, licenses, line of therapy, academic comparators, sales.

What is being tested here

Drugs under test in Arthritis, Gouty studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Coming up

11studies finish main data collection within a year2 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 10 Arthritis, Gouty studies recruiting now, 8 (80%) set no upper age limit and 1 (10%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 1 (10%) take healthy volunteers.

Recruiting studies that take each age, of 10
AgeWomenMen
100 (0%)0 (0%)
189 (90%)9 (90%)
309 (90%)9 (90%)
409 (90%)9 (90%)
5010 (100%)10 (100%)
6510 (100%)10 (100%)
7510 (100%)10 (100%)
859 (90%)9 (90%)

Across all 47 studies, recruiting or not: 28% stop at 75 or younger and 11% at 65; 6% take children; 0% are for women only and 2% for men only; 13% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

What changed recently

From the registry's own updates since Oct 19, 2026.

Studies

Recruiting first, then most recently updated. Showing 47 of 47. search them.